Aura Biosciences, Inc. SEC filings AURA
Aura Biosciences, Inc. has 381 filings in SEC EDGAR's recent list, going back to Sep 21, 2010. Its latest annual report, Form ARS, was filed on Apr 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 11, 2026 (results of operations, exit or restructuring costs, officer or director change, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Sep 1, 2026 | — |
| EFFECT | Filing | Aug 20, 2026 | — |
| CORRESP | Letter to the SEC | Aug 18, 2026 | — |
| UPLOAD | Letter from the SEC | Aug 17, 2026 | — |
| S-3 | Shelf registration | Aug 11, 2026 | — |
| 10-Q | Quarterly report | Aug 11, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Exit or restructuring costs, Officer or director change, Other events
|
Aug 11, 2026 | Aug 11, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 8, 2026 | Jul 3, 2026 |
| DEF 14A | Proxy statement | Jun 29, 2026 | Aug 5, 2026 |
| PRE 14A | Preliminary proxy statement | Jun 17, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 11, 2026 | Jun 11, 2026 |
| S-8 | Employee stock plan registration | May 19, 2026 | — |
| 10-Q | Quarterly report | May 11, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
May 11, 2026 | May 11, 2026 |
| 8-K |
Current report
Material agreement
|
May 5, 2026 | May 4, 2026 |
| 424B5 | Prospectus supplement | May 5, 2026 | — |
| 8-K |
Current report
Material agreement, Results of operations, Other events
|
May 4, 2026 | Apr 30, 2026 |
| DEFA14A | Additional proxy material | May 4, 2026 | — |
| S-3MEF | Filing | May 4, 2026 | — |
| 424B5 | Prospectus supplement | May 4, 2026 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure, Other events
|
May 4, 2026 | Apr 29, 2026 |
| ARS | Annual report to shareholders | Apr 20, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 20, 2026 | — |
| DEF 14A | Proxy statement | Apr 20, 2026 | Jun 11, 2026 |
| S-8 | Employee stock plan registration | Mar 30, 2026 | — |
| 10-K | Annual report | Mar 30, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Mar 30, 2026 | Mar 30, 2026 |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 13, 2025 | Nov 13, 2025 |
| 10-Q | Quarterly report | Aug 13, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 13, 2025 | Aug 13, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 18, 2025 | Jun 17, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
May 16, 2025 | May 15, 2025 |
| 424B5 | Prospectus supplement | May 16, 2025 | — |
| 424B5 | Prospectus supplement | May 15, 2025 | — |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Officer or director change
|
May 15, 2025 | May 13, 2025 |
| ARS | Annual report to shareholders | Apr 24, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 24, 2025 | — |
| DEF 14A | Proxy statement | Apr 24, 2025 | Jun 17, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 2, 2025 | Mar 31, 2025 |
| S-8 | Employee stock plan registration | Mar 24, 2025 | — |
| 10-K | Annual report | Mar 24, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Mar 24, 2025 | Mar 24, 2025 |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 12, 2024 | Nov 12, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 17, 2024 | Oct 17, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 27, 2024 | Sep 23, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 12, 2024 | Sep 12, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 21, 2024 | Jun 20, 2024 |
| DEFA14A | Additional proxy material | Jun 14, 2024 | — |
| 10-K/A | Amended annual report | Jun 14, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Other events
|
Jun 4, 2024 | Jun 4, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| ARS | Annual report to shareholders | Apr 25, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 25, 2024 | — |
| DEF 14A | Proxy statement | Apr 25, 2024 | Jun 20, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 15, 2024 | Apr 12, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 15, 2024 | Jun 20, 2024 |
| EFFECT | Filing | Apr 5, 2024 | — |
| CORRESP | Letter to the SEC | Apr 3, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 3, 2024 | — |
| S-3 | Shelf registration | Mar 27, 2024 | — |
| S-8 | Employee stock plan registration | Mar 27, 2024 | — |
| 10-K | Annual report | Mar 27, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 27, 2024 | Mar 27, 2024 |
| 8-K |
Current report
Other events
|
Jan 8, 2024 | Jan 8, 2024 |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Material agreement, Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 424B5 | Prospectus supplement | Nov 7, 2023 | — |
| 424B5 | Prospectus supplement | Nov 6, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 6, 2023 | Nov 6, 2023 |
| 8-K |
Current report
Officer or director change
|
Oct 2, 2023 | Sep 26, 2023 |
| 10-Q | Quarterly report | Aug 9, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 9, 2023 | Aug 9, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 7, 2023 | Jun 7, 2023 |
| 10-Q | Quarterly report | May 11, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations, Other events
|
May 11, 2023 | May 11, 2023 |
| ARS | Annual report to shareholders | Apr 25, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 25, 2023 | — |
| DEF 14A | Proxy statement | Apr 25, 2023 | Jun 7, 2023 |
| 8-K |
Current report
Officer or director change
|
Apr 4, 2023 | Apr 3, 2023 |
| S-8 | Employee stock plan registration | Mar 15, 2023 | — |
| 10-K | Annual report | Mar 15, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 15, 2023 | Mar 15, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 16, 2023 | Feb 16, 2023 |
| 8-K |
Current report
Other events
|
Jan 6, 2023 | Jan 6, 2023 |
| 8-K |
Current report
Material agreement
|
Dec 5, 2022 | Nov 30, 2022 |
| 424B5 | Prospectus supplement | Dec 1, 2022 | — |
| 424B5 | Prospectus supplement | Nov 30, 2022 | — |
| 8-K |
Current report
Other events
|
Nov 30, 2022 | Nov 30, 2022 |
| 10-Q | Quarterly report | Nov 10, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 10, 2022 | Nov 10, 2022 |
| EFFECT | Filing | Nov 7, 2022 | — |
| CORRESP | Letter to the SEC | Nov 3, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 3, 2022 | — |
| S-3 | Shelf registration | Nov 1, 2022 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 3, 2022 | Oct 2, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 28, 2022 | Sep 28, 2022 |
| 10-Q | Quarterly report | Aug 11, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2022 | Aug 11, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 30, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 22, 2022 | Jun 19, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 15, 2022 | Jun 15, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
May 27, 2022 | May 26, 2022 |
| 8-K |
Current report
Material agreement, New debt
|
May 18, 2022 | May 16, 2022 |
| 10-Q | Quarterly report | May 12, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 12, 2022 | May 12, 2022 |
| DEFA14A | Additional proxy material | Apr 28, 2022 | — |
| DEF 14A | Proxy statement | Apr 28, 2022 | Jun 15, 2022 |
| S-8 | Employee stock plan registration | Mar 23, 2022 | — |
| 10-K | Annual report | Mar 23, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 23, 2022 | Mar 23, 2022 |
| 10-Q | Quarterly report | Nov 24, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 24, 2021 | Nov 24, 2021 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Nov 2, 2021 | Nov 2, 2021 |
| 424B4 | Prospectus | Nov 1, 2021 | — |
| S-8 | Employee stock plan registration | Oct 29, 2021 | — |
| EFFECT | Filing | Oct 28, 2021 | — |
| S-1MEF | Filing | Oct 28, 2021 | — |
| SEC STAFF LETTER | Filing | Oct 28, 2021 | — |
| CERT | Filing | Oct 28, 2021 | — |
| 8-A12B | Filing | Oct 26, 2021 | — |
| CORRESP | Letter to the SEC | Oct 26, 2021 | — |
| CORRESP | Letter to the SEC | Oct 26, 2021 | — |
| CORRESP | Letter to the SEC | Oct 25, 2021 | — |
| S-1/A | Amended registration statement | Oct 25, 2021 | — |
| UPLOAD | Letter from the SEC | Oct 13, 2021 | — |
| CORRESP | Letter to the SEC | Oct 8, 2021 | — |
| S-1 | Registration statement | Oct 8, 2021 | — |
| UPLOAD | Letter from the SEC | Sep 27, 2021 | — |
| SEC STAFF LETTER | Filing | Sep 21, 2021 | — |
| DRS/A | Filing | Sep 20, 2021 | — |
| DRSLTR | Filing | Sep 17, 2021 | — |
| UPLOAD | Letter from the SEC | Sep 10, 2021 | — |
| DRS | Filing | Aug 10, 2021 | — |
| D | Filing | Apr 6, 2021 | — |
| D | Filing | Jul 9, 2020 | — |
| D | Filing | Apr 12, 2019 | — |
| D/A | Filing | Dec 13, 2018 | — |
| D | Filing | Jan 3, 2018 | — |
| D/A | Filing | Nov 2, 2017 | — |
| D | Filing | Sep 30, 2016 | — |
| D | Filing | Mar 5, 2015 | — |
| D | Filing | Aug 14, 2014 | — |
| D | Filing | Jan 8, 2014 | — |
| D | Filing | Dec 26, 2012 | — |
| D | Filing | Aug 26, 2011 | — |
| D | Filing | Sep 21, 2010 | — |
Showing 153 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- AURA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1501796
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.